Long-term changes of the prevalence and control rate of hypertension among Korean adults with diagnosed diabetes: 1998-2008 Korean National Health and Nutrition Examination Survey

Diabetes Research and Clinical Practice

Volumn 97, Issue 1, 2012, Pages 151-157

  Ko, Seung Hyun ^a   Kwon, Hyuk Sang ^a   Song, Ki Ho ^a   Ahn, Yu Bae ^a   Yoon, Kun Ho ^a   Yim, Hyeon Woo ^a   Lee, Won Chul ^a   Park, Yong Moon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Blood pressure; Diabetes mellitus; Hypertension; Korean National Health and Nutrition Examination Survey (KNHANES)

Indexed keywords

ANTIHYPERTENSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE; TREND STUDY;

ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; AWARENESS; BODY MASS INDEX; DIABETES COMPLICATIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NUTRITION SURVEYS; OBESITY; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84864078176     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.04.004     Document Type: Article

References (29)

1. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222. Emerging Risk Factors Collaboration.
2. Adler A.I., Stratton I.M., Neil H.A., Yudkin J.S., Matthews D.R., Cull C.A., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000, 321:412-419.
3. Tasosa J., Schuster R., McAlearney J.S. Cost-effectiveness of treating hypertension, hyperglycemia, and hyperlipidemia in African Americans and the general population with type 2 diabetes. J Health Care Poor Underserved 2010, 21:161-176.
4. American Diabetes Association Standards of medical care in diabetes. Diabetes Care 2007, 30(Suppl. 1):S4-S41.
5. Southwell A., Eckland D. Managing the burden of type 2 diabetes: an international survey of physicians. Pract Diabetes Int 1997, 14:201-206.
6. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713. UK Prospective Diabetes Study Group.
7. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000, 355:253-259. Heart Outcomes Prevention Evaluation Study Investigators.
8. Reboldi G., Gentile G., Angeli F., Ambrosio G., Mancia G., Verdecchia P. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients. J Hypertens 2011, 29:1253-1269.
9. Cushman W.C., Evans G.W., Byington R.P., Goff D.C., Grimm R.H., Cutler J.A., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 362:1575-1585.
10. Rutter M.K., Nesto R.W. Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care. Eur Heart J 2011, 32:2247-2255.
11. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
12. Ko S.H., Kim S.R., Kim D.J., Oh S.J., Lee H.J., Shim K.H., et al. 2011 Clinical Practice Guideline for Type 2 Diabetes in Korea. Diabetes Metab J 2001, 35:431-436.
13. International Diabetes Federation 2005. Global guideline for type 2 diabetes. Available from [accessed December 2011]. http://www.idf.org/.
14. Nilsson P.M., Cederholm J., Zethelius B.R., Eliasson B.R., Eeg-Olofsson K., Gudbj Rnsdottir S. Trends in blood pressure control in patients with type 2 diabetes? Data from the Swedish National Diabetes Register (NDR). Blood Press 2011, 20:348-354.
15. Wang J., Geiss L.S., Cheng Y.J., Imperatore G., Saydah S.H., James C., et al. Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008. Diabetes Care 2011, 34:1579-1581.
16. Thomas M.C., Atkins R. Assessment and management of hypertension in patients with type 2 diabetes. Intern Med J 2009, 39:143-149.
17. Suh D.C., Kim C.M., Choi I.S., Plauschinat C.A., Barone J.A. Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988-2004. J Hypertens 2009, 27:1908-1916.
18. McAlister F.A., Wilkins K., Joffres M., Leenen F.H., Fodor G., Gee M., et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
19. Korea Centers for Disease Control and Prevention (KCDC). Korea National Health and Nutrition Examination Survey. Available from [accessed 9 November 2011]. http://knhanes.cdc.go.kr/.
20. Geiss L.S., Rolka D.B., Engelgau M.M. Elevated blood pressure among U.S. adults with diabetes, 1988-1994. Am J Prev Med 2002, 22:42-48.
21. Lim S., Shin H., Song J.H., Kwak S.H., Kang S.M., Won Yoon J., et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011, 34:1323-1328.
22. Patel A., MacMahon S., Chalmers J., Neal B., Woodward M., et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007, 370:829-840. ADVANCE Collaborative Group.
23. Turnbull F., Neal B., Algert C., Chalmers J., Chapman N., Cutler J., et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005, 165:1410-1419.
24. Kim J.H., Kim D.J., Jang H.C., Choi S.H. Epidemiology of micro- and macrovascular complications of type 2 diabetes in Korea. Diabetes Metab J 2011, 35:571-577.
25. Korean Diabetes Association, Health Insurance Review & Assessment Service Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus. Diabetes in Korea 2007. Seoul; 2007.
26. Charpentier G., Genès N., Vaur L., Amar J., Clerson P., Cambou J.P., et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab 2003, 29:152-158.
27. Ministry of Health and Welfare 2010 A guide for chronic disease management program 2010, Ministry of Health and Welfare, Seoul, South Korea.
28. Ministry of Health and Welfare 2010 National Nutrition Survey Report 1997, Ministry of Health and Welfare, Seoul, South Korea.
29. Park Y. Why is type 1 diabetes uncommon in Asia?. Ann N Y Acad Sci 2006, 1079:31-40.